Evidence review · Published July 22, 2026 · Sources checked July 22, 2026
SS-31 (elamipretide) research overview
SS-31, also called elamipretide in clinical-development literature, is a mitochondria-targeted aromatic-cationic tetrapeptide.
Evidence boundary: published research does not establish the identity or performance of a separately supplied batch. The catalog product is supplied only for qualified in vitro laboratory research and is not for human or animal use.
What is SS-31?
Biophysical and biochemical studies have examined membrane surface electrostatics, cardiolipin-associated cytochrome c behavior, and mitochondrial protein interactions.
- Research category
- Mitochondrial & cellular aging
- Study models represented
- Biophysical systems, isolated mitochondria, cells, animals, and a controlled human mechanistic study
- Names in the literature
- Elamipretide; MTP-131; Szeto-Schiller peptide 31
- Primary boundary
- Mechanistic and small human studies do not establish broad clinical efficacy or product interchangeability.
What does the selected evidence support?
A randomized study in older adults examined skeletal-muscle mitochondrial energetics after a controlled intervention. That finding is protocol-specific and does not establish equivalence of separately sourced material.
Primary sources
- Birk et al., British Journal of Pharmacology (2014) — Cardiolipin/cytochrome-c interaction and mitochondrial mechanism experiments. DOI: 10.1111/bph.12468
- Chavez et al., PNAS (2020) — Cross-linking mass-spectrometry study of the mitochondrial protein interaction landscape. DOI: 10.1073/pnas.2002250117
- Campbell et al., JCI Insight (2021) — Randomized human study measuring skeletal-muscle mitochondrial energetics in older adults. DOI: 10.1172/jci.insight.146353
Research literature and product documentation are different
A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.
Review SS-31 product specifications · Browse the COA library · Read the research-use policy
Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.